Pablo Barreiro Selected Research

Pablo Barreiro Research Topics

Disease

47	Hepatitis C 01/2023 - 01/2005
43	Chronic Hepatitis C 06/2016 - 05/2003
38	Infections 01/2023 - 02/2004
29	HIV Infections (HIV Infection) 01/2023 - 10/2002
27	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2006
15	Fibrosis (Cirrhosis) 01/2017 - 12/2004
12	Chronic Hepatitis B 01/2023 - 09/2006
12	Liver Diseases (Liver Disease) 01/2017 - 12/2004
11	COVID-19 10/2023 - 01/2020
11	Coinfection 01/2023 - 10/2005
10	Viremia 07/2017 - 07/2003
9	Hepatitis D 01/2023 - 11/2011
8	Hepatitis B 01/2023 - 05/2006
7	Virus Diseases (Viral Diseases) 12/2023 - 12/2004
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 07/2002
5	Hepatitis 01/2023 - 01/2010
5	Neoplasms (Cancer) 01/2023 - 03/2015
4	Renal Insufficiency (Renal Failure) 01/2023 - 03/2009
4	Anemia 12/2011 - 08/2005
4	End Stage Liver Disease 03/2010 - 05/2006
3	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2017
3	Disease Progression 01/2023 - 05/2018
3	Portal Hypertension 05/2010 - 01/2008
3	Hyperbilirubinemia 11/2008 - 01/2006
3	Pancreatitis 09/2006 - 05/2003
2	Human Influenza (Influenza) 12/2023 - 01/2022
2	Reinfection 01/2022 - 04/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 08/2006
2	Syphilis 01/2018 - 10/2013
2	Chronic Hepatitis (Chronic Active Hepatitis) 08/2013 - 05/2006
2	Inflammation (Inflammations) 05/2013 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2009 - 10/2002
2	Insulin Resistance 06/2008 - 04/2008
2	Hepatocellular Carcinoma (Hepatoma) 05/2006 - 12/2004
2	Lipodystrophy 07/2005 - 10/2002
1	Progeria (Hutchinson Gilford Syndrome) 01/2023
1	Poliomyelitis (Polio) 01/2022
1	Breakthrough Infections 01/2022
1	Measles 01/2022
1	Severe Acute Respiratory Syndrome 01/2021
1	Acute Generalized Exanthematous Pustulosis 09/2020

Drug/Important Bio-Agent (IBA)

45	Antiviral Agents (Antivirals)IBA 12/2023 - 03/2008
30	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 05/2003
27	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2003
26	InterferonsIBA 01/2015 - 08/2004
16	Tenofovir (Viread)FDA Link 01/2023 - 04/2006
11	VaccinesIBA 03/2022 - 09/2015
7	Didanosine (Videx)FDA LinkGeneric 05/2010 - 05/2003
6	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 05/2008
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2017 - 09/2006
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2015 - 10/2002
5	Transaminases (Aminotransferases)IBA 01/2008 - 05/2003
4	SofosbuvirIBA 01/2023 - 01/2016
4	Immunoglobulin G (IgG)IBA 03/2022 - 01/2021
4	AntigensIBA 01/2022 - 04/2007
4	Lamivudine (Epivir)FDA Link 02/2015 - 10/2007
4	Atazanavir Sulfate (Reyataz)FDA Link 07/2009 - 01/2006
3	Alanine Transaminase (SGPT)IBA 05/2013 - 04/2006
3	efavirenz (Sustiva)FDA Link 10/2007 - 07/2003
3	NucleosidesIBA 03/2007 - 07/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2020
2	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link 01/2018 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2013
2	Emtricitabine (Emtriva)FDA Link 01/2018 - 05/2008
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2017 - 03/2015
2	entecavir FDA Link 07/2017 - 05/2008
2	Hemoglobins (Hemoglobin)IBA 06/2017 - 04/2010
2	InterleukinsIBA 11/2013 - 03/2012
2	Hepatitis B e AntigensIBA 09/2013 - 04/2007
2	telaprevirIBA 01/2013 - 09/2012
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2013 - 09/2012
2	Inosine TriphosphataseIBA 03/2012 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2010 - 10/2002
2	LipidsIBA 01/2010 - 10/2002
2	Interferon-alpha (Interferon Alfa)IBA 05/2008 - 08/2005
2	Nevirapine (Viramune)FDA Link 04/2008 - 07/2003
2	EnzymesIBA 01/2008 - 12/2004
2	Zidovudine (Retrovir)FDA LinkGeneric 09/2006 - 03/2006
2	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2006 - 06/2004
1	Genetic Markers (Genetic Marker)IBA 10/2023
1	COVID-19 VaccinesIBA 10/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	lonafarnib (SCH 66336)IBA 01/2023
1	Messenger RNA (mRNA)IBA 03/2022
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 10/2021
1	Guanosine Diphosphate (GDP)IBA 01/2021

Therapy/Procedure

83	Therapeutics 01/2023 - 07/2002
13	Highly Active Antiretroviral Therapy (HAART) 03/2015 - 10/2002
3	Duration of Therapy 06/2013 - 08/2007
2	Drug Therapy (Chemotherapy) 01/2023 - 09/2015
2	Aftercare (After-Treatment) 09/2020 - 11/2006
2	Organ Transplantation 01/2020 - 09/2017
2	Art Therapy 06/2014 - 05/2013
1	Transplantation 01/2023
1	Chemoprevention 01/2022
1	Home Nursing (Nursing, Home) 01/2021